Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
1988 • 19,632 citations
Revised Criteria for the Classification of Rheumatoid Arthritis
1990 • 7,730 citations
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
1995 • 5,929 citations
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 • 2,992 citations
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
1995 • 2,778 citations
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 • 2,229 citations
<scp>gp</scp>130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
1997 • 1,468 citations
Etanercept Therapy in Rheumatoid Arthritis
1999 • 1,407 citations
The Pathophysiologic Roles of Interleukin-6 in Human Disease
1998 • 1,132 citations
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
1998 • 956 citations
Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
1988 • 859 citations
Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis
1988 • 793 citations
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
1996 • 538 citations
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.
1989 • 514 citations
Textbook of Rheumatology
1994 • 434 citations
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
1992 • 377 citations
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.
1994 • 299 citations
Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
1993 • 278 citations
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
2000 • 210 citations
lnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases
1988 • 143 citations
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.
1992 • 133 citations
Long-Term Outcomes in Rheumatoid Arthritis
1995 • 114 citations
Interleukin-6 and its receptor in autoimmunity
1992 • 82 citations
Management of rheumatoid arthritis
1997 • 26 citations
Antirheumatic gold compounds and penicillamine enhance protein kinase C-mediated activation of the arachidonate- mobilizing phospholipase A2 in mouse macrophages
1993 • 13 citations
IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs
1992 • 6 citations